Contact
Login
|
Patients
Contact
Portal Login

News

BioTelemetry, Inc. to Release Second Quarter 2019 Earnings Results on July 30, 2019

MALVERN, Pa., July 19, 2019 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT) will release its second quarter 2019 earnings on Tuesday, July 30 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Tuesday, July 30, 2019.  The broadcast will be available through the investor information section of the BioTelemetry website www.gobio.com.  If you are unable to participate during the live webcast, an archive will be available on our website for two weeks. About BioTelemetry BioTelemetry, Inc. is the leading remote medical technology company focused on delivery of health information to improve quality of life and reduce cost of care.  We provide remote cardiac monitoring, remote blood glucose monitoring, centralized core lab services for clinical trials and original

BioTelemetry, Inc. Reports First Quarter 2019 Financial Results

Achieves Record Quarterly Revenue Raises Full Year 2019 Guidance MALVERN, Pa., April 25, 2019 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the first quarter ended March 31, 2019. Quarter Highlights Recognized record quarterly revenue of $104.0 million Reached 10.0% year-over-year revenue growth Achieved 27th consecutive quarter of year-over-year revenue growth Reported GAAP net income of $11.7 million Realized quarterly adjusted EBITDA of $28.8 million, or 27.7% of revenue Completed the acquisition of Geneva Healthcare Raises full year 2019 revenue guidance to $446 to $450 million President and CEO Commentary Joseph H. Capper, President and Chief Executive Officer of BioTelemetry,

BioTelemetry, Inc. to Release First Quarter 2019 Earnings Results on April 25, 2019

MALVERN, Pa., April 18, 2019 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT) will release its first quarter 2019 earnings on Thursday, April 25 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Thursday, April 25, 2019.  The broadcast will be available through the investor information section of the BioTelemetry website www.gobio.com.  If you are unable to participate during the live webcast, an archive will be available on our website for two weeks. About BioTelemetry BioTelemetry, Inc. is the leading remote medical technology company focused on delivery of health information to improve quality of life and reduce cost of care.  We provide remote cardiac monitoring, remote blood glucose monitoring, centralized core lab services for clinical trials and original

Telcare, a Division of BioTelemetry, Inc., Announces Collaboration with Onduo in Diabetes Management Program

Telcare, the manufacturer of the world’s first FDA-cleared cellular-enabled blood glucose monitor, has entered into a strategic collaboration with Onduo, a joint venture created by Verily (an Alphabet company) and Sanofi. Under this partnership, Telcare will serve as the supplier of remote blood glucose systems and the resulting data for patients enrolled in Onduo’s groundbreaking diabetes management program.

View All Post

Stay up-to-date and subscribe to our newsletter

Sign up to stay informed and receive information on healthcare innovation, straight to your inbox
Subscribe now

© 2023 BioTelemetry, a Philips Company. All rights reserved